|
1 |
25 06 2026 |
NPPA asks cos to file quarterly data on production and sale of NLEM drugs |
Pharmabiz |
India |
|
2 |
25 06 2026 |
Regulators turn to Advanced analytical methods to root out EG, DEG in medicines |
Health world (Economic Times) |
India |
|
3 |
25 06 2026 |
Govt merges medicine price, complaint portals into single citizen platform |
Health world (Economic Times) |
India |
|
4 |
25 06 2026 |
NITI Aayog proposes pharma chapter for future FTAs, urges India to move up value chain |
Health world (Economic Times) |
India |
|
5 |
25 06 2026 |
UNICEF, Gavi launch call to speed Bundibugyo Ebola vaccine access |
Health world (Economic Times) |
India |
|
6 |
25 06 2026 |
BDR Pharma launches new injectable to treat drug resistant infections |
Biospectrum |
India |
|
7 |
25 06 2026 |
EFPIA report adds to pressures on EU drug pricing policy |
Pharmaphorum |
France |
|
8 |
25 06 2026 |
Honasa acquires 58% stake in Fluence Pharma for $15-18 million |
Startup .Economic Times |
India |
|
9 |
25 06 2026 |
Big duty cuts to power up API supply chain: pharma leaders |
Daily Star |
Bangladesh |
|
10 |
25 06 2026 |
Beyond GLP-1's: The next chapter of Obesity care |
Medical Dialogues |
India |
|
11 |
24 06 2026 |
India’s pharma supply chain dependent on Chinese imports, says NITI Aayog |
The Pioneer |
India |
|
12 |
24 06 2026 |
Indian pharma firms gear up to supply key cancer drug to US |
Health world (Economic Times) |
India |
|
13 |
24 06 2026 |
After initial rush, semaglutide therapy market saddled with ₹100 cr excess stock |
Health world (Economic Times) |
India |
|
14 |
24 06 2026 |
Drugmakers yet to see gains from government's minimum import price policy |
Health world (Economic Times) |
India |
|
15 |
24 06 2026 |
The cancer-drug paradox: US seeks Indian pharma help as India fixes its own chemo shortage |
Money Control |
India |
|
16 |
24 06 2026 |
CPHI/ Hi Korea 2026 Opens Pre-Registration: Korea's Hub for Pharma, Biopharma, and Health Innovation |
PR News Wire |
South Korea |
|
17 |
24 06 2026 |
Pharma exports grew over 6% in May |
Pharmabiz |
India |
|
18 |
24 06 2026 |
Decriminalisation of provisions under Jan Vishwas Act to come into force from June 30, 2027 |
Pharmabiz |
India |
|
19 |
24 06 2026 |
AIOCD recognizes S.A. Ramesh as TNCDA president & G Ashok as gen secretary following court order |
Pharmabiz |
India |
|
20 |
23 06 2026 |
DoP considering revision of GTE Exemption List of Medical Devices |
Pharmabiz |
India |
